LONGEVERON INC-A (LGVN)

US54303L2034 - Common Stock

4.39  +0.5 (+12.85%)

After market: 4.27 -0.12 (-2.73%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

LONGEVERON INC-A

NASDAQ:LGVN (7/12/2024, 5:05:59 PM)

After market: 4.27 -0.12 (-2.73%)

4.39

+0.5 (+12.85%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS SubIndustry
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Chartmill High Growth Momentum
EPS Q2Q%
Sales Q2Q%
CRS
6 Month-61.83%
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap27.88M
Shares
PEN/A
Fwd PEN/A
Dividend YieldN/A
Analysts
IPO
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

LGVN Daily chart

Company Profile

Longeveron, Inc. is a clinical stage biotechnology company. The company is headquartered in Miami, Florida and currently employs 19 full-time employees. The company went IPO on 2021-02-12. The firm's lead investigational product is the LOMECEL-B cell-based therapy product (Lomecel-B), which is derived from culture-expanded medicinal signaling cells (MSCs) that are sourced from bone marrow of young healthy adult donors. The firm is primarily focused on three pipeline indications, such as aging related frailty, Alzheimer's disease (AD), acute respiratory distress syndrome (ARDS), and hypoplastic left heart syndrome (HLHS). Its Lomecel-B has multiple mechanisms of action encompassing pro-vascular, pro-regenerative, anti- inflammatory, and tissue repair and healing effects with potential applications across a spectrum of disease areas. The firm has bone marrow supply contracts in with two suppliers: the Oklahoma Blood Institute and Vista Health Research.

Company Info

LONGEVERON INC-A

1951 NW 7th Ave, Ste 520

Miami FLORIDA 33136

P: 13053027158

CEO: Geoff Green

Employees: 19

Website: https://www.longeveron.com/

LGVN News

ChartMill News Image2 days ago - ChartmillWhat's going on in today's session

Top movers analysis one hour before the close of the markets on 2024-07-10: top gainers and losers in today's session.

ChartMill News Image2 days ago - ChartmillWednesday's session: most active stocks

Wednesday's session is buzzing with activity. Check out the stocks that are attracting the most attention and driving market activity!

ChartMill News Image2 days ago - ChartmillTop movers in Wednesday's session

Wondering how the US markets performed in the middle of the day on Wednesday? Discover the movers and shakers of today's session in our comprehensive analysis.

News Image2 days ago - InvestorPlacePLUG Stock: Plug Power Shares Hydrogen Refueling Station Update

Plug Power stock is up on Wednesday after the company provided investors with an update on its hydrogen refueling stations in Europe.

News Image2 days ago - InvestorPlaceWhy Is Kazia Therapeutics (KZIA) Stock Up 300% Today?

Kazia Therapeutics stock is heading higher on Wednesday as KZIA investors celebrate positive clinical trial news from the company.

News Image2 days ago - InvestorPlaceWhy Is Virpax Pharmaceuticals (VRPX) Stock Up 98% Today?

Virpax Pharmaceuticals stock is up on Wednesday as VRPX shareholders celebrate successful results from a swine model study.

LGVN Twits

Here you can normally see the latest stock twits on LGVN, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example